Inhaled anticholinergics associated with increased risk of mortality and MI in COPD patients

Compared with control, anticholinergics were associated with higher rates of cardiovascular death in analysis of 12 trials with 12,376 patients, MI in analysis of 11 trials with 10,598 patients, and all-cause mortality in analysis of 17 trials with 14,783 patients.